Influence of anticoagulant therapy with vitamin K antagonists on plasma levels of coagulation factor VIII

Thrombosis Research

Volumn 126, Issue 3, 2010, Pages 243-245

  Passamonti, Serena Maria ^a   Bucciarelli, Paolo ^a   Bader, Rossella ^a   Martinelli, Ida ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Factor VIII; venous thrombosis; vitamin K antagonists

Indexed keywords

ANTIVITAMIN K; BLOOD CLOTTING FACTOR 8;

ADULT; AGE DISTRIBUTION; ANTICOAGULANT THERAPY; ARTICLE; BLOOD SAMPLING; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCREENING TEST; SEX DIFFERENCE; THROMBOPHILIA; TREATMENT WITHDRAWAL; VEIN THROMBOSIS;

ADULT; ANTICOAGULANTS; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; FACTOR VIII; FEMALE; HUMANS; ITALY; LINEAR MODELS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS; VITAMIN K;

EID: 77956264821     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.01.017     Document Type: Article

References (15)

1. R.A. Kraaijenhagen in't Anker PS, Koopman MMW, Reitsma PH, Prins MH, van den Ende A et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism Thromb Haemost 83 1 2000 5 9
2. I. Bank, M.H. van de Poel, M. Coppens, K. Hamulyák, M.H. Prins, and J. van der Meer Absolute annual incidence of first event of venous thromboembolism and artherial vascular events in individuals with elevated FVIII:c. A prospective family cohort study Thromb Haemost 98 5 2007 1040 1044
3. J. O'Donnell, A.D. Mumford, R.A. Manning, and M. Laffan Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase reaction Thromb Haemost 83 1 2000 10 13
4. J. O'Donnell, E.G. Tuddenham, R. Manning, G. Kemball-Cook, D. Johnson, and M. Laffan High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction Thromb Haemost 77 5 1997 825 828
5. E. Yigit, G. Gonullu, I. Yucel, M. Turgut, D. Erdem, and B. Cakar Relation between hemostetic parameters and prognostic/predictive factors in breast cancer Eur J Intern Med. 19 8 2008 Dec 602 607
6. A. Tripodi, F. Salerno, V. Chantarangkul, M. Clerici, M. Cazzaniga, and M. Primignani Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests Hepatology 41 3 2005 553 558
7. M. Hellgren Hemostasis during normal pregnancy and puerperium Sem Thromb Haemost. 29 2 2003 Apr 125 130
8. G.D.O. Lowe, A. Rumley, M. Woodward, C.E. Morrison, H. Philippou, D.A. Lane, and H. Tnstall-Pedoe Epidemiology of coagulation factors, inhibithors and activation markers : the Third Glasgow MONICA Survey. I. Illustrative ranges by age, sex and hormone use Br J Haematol 97 4 1997 775 784
9. L. Poller, and J. Thomson Evidence for rebound " hypercoagulability" after stopping anticoagulants Lancet 2 1964 62 64
10. G. Palareti, C. Legnani, M. Frascaro, G. Guazzaloca, and S. Cocchieri Factor VIII:C levels during oral anticoagulation and after its withdrawal Thromb Haemost 74 6 1995 1609 1610
11. J.W.J. van Wersch Non vitamin-K-dependent clotting factors during oral anticoagulation treatment Blood Coagulat Fibrinol 3 6 1992 727 730
12. P.M. Mannucci, and A. Tripodi Factor VIII clotting activity J. Jespersen, R.M. Bertina, F. Haverkate, Laboratory techniques in thrombosis. A manual 1999 Kluwer Academic Publishers Dordrecht 107 113
13. A. Tripodi Review of the clinical and diagnostic utility of laboratory tests for the detection of congenital thrombophilia Sem Thromb Haemost 31 1 2005 25 32
14. P. Kyrle, E. Minar, M. Hirschl, C. Bialonczyk, M. Stain, and B. Schneider High plasma levels of factor VIII and the risk of recurrent venous thromboembolism N Engl J Med 343 7 2000 457 462
15. L. Eischer, V. Gartner, S. Schulman, P. Kyrle, and S. Eichinger 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with factor VIII Ann Hematol 88 5 2008 485 490